GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Net Issuance of Debt

Cytophage Technologies (TSXV:CYTO) Net Issuance of Debt : C$0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Cytophage Technologies's net issuance of debt for the three months ended in Mar. 2025 was C$-0.08 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.00 Mil.

Cytophage Technologies Net Issuance of Debt Historical Data

The historical data trend for Cytophage Technologies's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Net Issuance of Debt Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Issuance of Debt
-0.13 -0.15 -0.19 -0.04

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.10 -0.08 0.25 -0.08

Cytophage Technologies Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Net Issuance of Debt
Comparable Companies
TSXV:IBO XCNQ:BIOV TSXV:IOT XCNQ:GLOW TSXV:KNE XCNQ:BLAB TSXV:RKV TSX:RVX XCNQ:BETR TSX:APS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
CPTCF:USA
Address
200A - 400 Fort Whyte Way, Oak Bluff, Oak Bluff, MB, CAN, R4G 0B1
Website
https://www.cytophage.com
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics.

Cytophage Technologies Headlines

No Headlines